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&p.1:Abstract. The spatial and temporal distribution of three
peptides, DSK I, DSK II, and DSK 0, encoded by the
Drosophila melanogasterdrosulfakinin (Dsk) gene,
have been examined in the central nervous system. DSK
I and DSK II have a -RFamide C-terminus and are
structurally similar to sulfakinin peptides; in contrast,
DSK 0 contains -SFamide and is not structurally similar
to sulfakinins. Antisera specificities were determined by
the design of the antigens and confirmed by dot blot
analysis and preincubation with peptides prior to their
use in immunocytochemistry. The distribution of immu-
noreactivity suggests that all three DSK peptides are
processed from the polypeptide precursor and expressed
in many of the same cells. Expression was observed at
all developmental stages with an increase in the level of
staining and the number of immunoreactive cells as de-
velopment progresses. Cells in the brain lobe, optic
lobe, subesophageal ganglion, thoracic ganglia, and the
eighth abdominal neuromere contain DSK-immunoreac-
tive materials. Immunoreactive fibers project from some
cells and extend into the brain and ventral ganglion with
regions of extensive arborization. DSK 0 immunoreac-
tivity provides initial evidence for the presence of a
-SFamide peptide in neural tissue. The observed expres-
sion of DSK-immunoreactive materials throughout de-
velopment in numerous cells of the central nervous
system suggests that DSK peptides may serve as hor-
mones, modulators, or transmitters involved in several
functions.
&kwd:Key words: FMRFamide – Cholecystokinin – Neuro-
peptides – Fruit fly, Drosophila melanogaster(Insecta)
Introduction
Several studies have established that peptides present in
the central nervous system can act as hormones, modula-
tors, or transmitters of important physiological functions
(Krieger 1983). In recent years numerous neuropeptides
have been detected by bioassays, immunocytochemistry,
and radioimmunoassays. Further studies to isolate and
determine the structures of these peptides have resulted
in the finding that these neuropeptides can frequently be
grouped into families based on structure or activity, and
that invertebrate and vertebrate neural tissue often con-
tain homologous peptides.
One family of peptides, the sulfakinins, is related by
structure and activity. Two sulfakinin peptides, leucosulfa-
kinin (LSK) and leucosulfakinin II (LSK II), were identi-
fied from cockroach brain tissue by means of a gut motili-
ty assay (Nachman et al. 1986a, b). Subsequently, sulfaki-
nin peptides have been isolated from other insects includ-
ing the cockroach Periplaneta americana(Veenstra 1990),
the locust Locusta migratoria(Schoofs et al. 1990), the
fruit fly Drosophila melanogaster(Nichols 1992a), and
the flesh fly Neobellieria bullata(Fonágy et al. 1992).
Sulfakinin peptides are members of a larger family of
peptides with a common C-terminal RFamide structure.
In addition, sulfakinin peptides are homologous to the
vertebrate neuropeptide cholecystokinin (CCK) based on
structure similarity and the requirement for a sulfated ty-
rosyl residue to induce gut motility (Nachman et al.
1986a, b).
Peptides containing -RFamide have been shown to be
abundant, widely distributed peptides involved in impor-
tant physiological functions (Raffa 1988). Using antisera
to FMRFamide, the distribution of -RFamide peptides
has been extensively studied in the Drosophila melano-
gastercentral nervous system (White et al. 1986; Lund-
quist and Nässel 1990). In contrast, no prior immuno-
cytochemical or peptide isolation study has reported the
identification of a -SFamide peptide.
The Drosophila melanogastersulfakinin gene can be
predicted to encode three non-overlapping peptides:
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DSK I, DSK II, and DSK 0 (Nichols et. al. 1988). Based
on nucleotide sequence and putative processing sites, the
structures are: PheAspAspTyrGlyHisMetArgPheamide
(DSK I), GlyGlyAspAspGlnPheAspAspTyrGlyHisMet-
ArgPheamide (DSK II), and AsnGlnLysThrMetSerPhe-
amide (DSK 0). DSK I and DSK II differ in structure by
a five amino acid N-terminal extension present in DSK
II and share a high degree of structure homology with
sulfakinin peptides isolated from other invertebrates. In
contrast, DSK 0 is not similar in structure to sulfakinins,
and no structural homologue has been isolated, suggest-
ing that DSK 0 may be a novel peptide.
Our study of the Drosophila melanogastersulfakinin
peptides has included the isolation of DSK I and detec-
tion of DSK-specific immunoreactive material in larval
neural tissue (Nichols 1992a). In this manuscript we re-
port the spatial and temporal expression patterns of the
DSK peptides in the Drosophila melanogastercentral
nervous system using antisera raised to antigens distin-
guishing DSK II from DSK I and DSK 0, and DSK 0
from DSK I and DSK II, and antisera raised to DSK I.
The data presented here indicate that DSK-immunoreac-
tive materials are present throughout development in
several cell bodies in the brain lobe, optic lobe, sub-
esophageal ganglion, thoracic ganglia, and an abdominal
ganglion, and immunoreactive fibers that project from




Drosophila melanogasterOregon R flies were raised on cornmeal
molasses medium and maintained at 25°C. At each developmental
stage, neural tissue was dissected from flies of a known age. Flies
were collected for dissection based on the number of hours after
egg laying for embryonic tissue, after hatching for larval tissue,
after becoming white prepupae for pupal tissue, and after eclosing
for adult tissue. No fewer than six tissue preparations were ana-
lyzed for each developmental time point.
Antigen design and antisera production
Peptides used as antigens were synthesized with an Applied Bio-
systems model 431 solid phase synthesizer, purified by prepara-
tive reversed-phase high performance liquid chromatography, and
the structures confirmed by mass spectrometry.
Antisera were raised to the synthetic peptide PheAspAspTyr-
GlyHisMetArgPheamide (DSK I) as previously described (Ni-
chols 1992a). The antisera were purified on a FMRFamide peptide
affinity column to remove antisera to -MRFamide, a structure that
DSK I and DSK II have in common with FMRFamide-containing
peptides. To ensure the removal of antisera recognizing MRFam-
ide, the binding capacity of the resin was higher than the amount
of antisera applied and the antisera were passed over the column
several times. Antisera that did not bind to the FMRFamide pep-
tide column were characterized by means of a solid phase dot blot
assay. Since these antisera were raised to an antigen present in
both DSK I and DSK II, they are referred to as DSK I/II antisera.
The DSK I/II antisera used in this study were a higher titer antise-
ra than those used in a previously reported study (Nichols 1992a).
Antisera to DSK II were generated to the five amino acid N-
terminal extension, GlyGlyAspAspGln, which distinguishes DSK
II from DSK I. The antigen was made as a multiple antigenic pep-
tide or MAP, in which multiple copies of the antigen are synthe-
sized on a branched polylysyl core (Postnett and Tam 1989). A
peptide affinity column containing GlyGlyAspAspGln-MAP cou-
pled to Affi-gel 10 (Bio-Rad Labs) in dry dimethyl sulfoxide and
1% triethylamine was used to purify antisera to DSK II according
to a previously described method (Nichols 1992a; McCormick
and Nichols 1993). These antisera are referred to as DSK II anti-
sera.
The antisera used to recognize DSK 0-immunoreactive materi-
al were raised to the synthetic peptide AsnGlnLysThrMetSerPhe-
amide (DSK 0). For use as an antigen, the peptide was conjugated
to succinylated thyroglobulin through the lysyl residue and N-ter-
minus of the peptide by means of carbodiimide coupling with
EDAC (Yamada et al. 1981). These antisera are referred to as
DSK 0 antisera.
Antisera were raised in New Zealand white rabbits. The initial
immunizations were by subcutaneous injections at multiple sites
of a total of 0.5 mg of antigen emulsified in Freund’s complete ad-
juvant. Subsequent boosts were given every 2 weeks by subcuta-
neous injections of 0.5 mg of antigen emulsified in incomplete
Freund’s adjuvant. Antisera titers were analyzed by indirect im-
munocytochemistry of whole-mount third-instar larval central ner-
vous systems as previously described (McCormick and Nichols
1993).
Immunocytochemistry.
The data reported in this manuscript are from whole-mount tissue
preparations in which the central nervous system was dissected
cleanly away from other tissue. The tissue was dissected in cold
Ringer’s solution and prepared for indirect immunohistochemistry
according to a previously published procedure (McCormick and
Nichols 1993). Tissue was fixed in paraformaldehyde for 4 h or
longer at 4°C, washed in PTN (0.5 M sodium phosphate, pH 7.2,
containing 0.01% Triton X-100, 0.1% bovine serum albumin
(BSA), and 0.1% sodium azide), incubated for 2 h or longer at
4°C with primary antisera, washed extensively in PTN, incubated
for 2 h or longer at 4°C with fluorescein isothiocyanate (FITC;
Sigma) or indocarbocyanine (CY3; Jackson ImmunoResearch)-la-
beled goat anti-rabbit antisera, and washed extensively in PTN
prior to viewing.
Microscopy and data collection
Fluorescence signal was imaged with a BioRad MRC600 scan-
ning confocal microscope equipped with a Kr-Ar laser and at-
tached to a Nikon inverted microscope. Data were processed with
Adobe Photoshop and transferred to slide film with a Macintosh
Quadra 800 and Lasergraphics LFR-X.
Results
The nomenclature used to identify cells expressing DSK
immunoreactive is from White et al. 1986; Schneider et
al. 1991; O’Brien et al. 1991; McCormick and Nichols
1993; Tibbetts and Nichols 1993. Identification is based
on position when compared to cells expressing FMRF-
amide-immunoreactive materials. The description of the
number of immunoreactive cells in the central nervous
system takes into account the observation that the cells
and fibers were all bilaterally symmetric to the midline,
i.e., the report of immunoreactivity in one cell indicates
that two immunoreactive cells, bilateral to the midline,
were present. The staining patterns did not vary when
comparing tissue dissected from females and males.
Antisera specificity
The specificity of each antisera was determined by the
design of the antigen and confirmed by solid phase dot
blot assay and by preincubation of the antisera with
10–4M and 10–6M synthetic peptide prior to use in im-
munocytochemistry. Antisera that did not bind to the
FMRFamide peptide affinity column are DSK I/II-spe-
cific antisera and crossreact with DSK I and DSK II, but
not DSK 0 or FMRFamide as analyzed by dot blot. Incu-
bation of DSK I/II antisera with DSK 0 or FMRFamide
prior to use in immunocytochemistry did not alter the
pattern of immunoreactivity, while preincubation with
DSK I or DSK II abolished all signal.
DSK II antisera recognize DSK II but not DSK 0,
DSK I, or FMRFamide. Incubation of DSK II antisera
with DSK 0, DSK I, or FMRFamide prior to use in im-
munocytochemistry did not alter the pattern of immuno-
reactivity, while preincubation with GlyGlyAspAspGln
abolished all signal.
DSK 0 antisera recognize DSK 0 but not DSK I, DSK
II, or FMRFamide. Incubation of DSK 0 antisera with
DSK I, DSK II, or FMRFamide prior to use in immuno-
cytochemistry did not alter the pattern of immunoreac-
tivity, while preincubation with DSK 0 abolished all sig-
nal. Preincubation of DSK 0 antisera with SFamide re-
duced the overall staining but did not abolish signal in
any individual cell.
DSK I/II immunoreactivity
DSK I/II staining was first detected in neural tissue dis-
sected from embryos at 16 h. Weak but consistent signal
was observed in one cell in the subesophageal ganglion
(SE2) and two cells in the medial protocerebrum (MP1;
data not shown).
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Fig. 1. DSK I/II immunoreactivity in larval neural tissue at 96 h.
Immunoreactive material is expressed in SP1, SP2, SP3, LP1,
MP1, SE2, Tv1–3, T2dm, and A8 cells. An immunoreactive fiber
projects away from the central nervous system in an abdominal
ganglion (filled arrow). Bar: 50µm&/fig.c:
Fig. 2. DSK I/II immunoreactivity in larval protocerebrum and
subesophageal ganglion at 96 h. Immunoreactive material is ex-
pressed in SP1, SP2, SP3, LP1, MP1, Sv, and SE2 cells. Immuno-
reactive fibers project from the MP1 cells – one extends through
the subesophageal ganglion into the ventral ganglion, while an-
other crosses the midline, turns and extends through the sub-
esophageal ganglion into the ventral ganglion. Bar: 50µm&/fig.c:
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Numerous cells express DSK I/II-immunoreactive
material in neural tissue dissected from larvae at 96 h
(Fig. 1). Multiple cells in the superior protocerebrum
(SP1, SP2, and SP3), two cells in the medial protocere-
brum (MP1), one cell in the lateral protocerebrum (LP1),
one cell in the subesophageal ganglion (SE2), one cell in
each of the three thoracic ganglia (Tv1–3), and two cells
in the eighth abdominal ganglion (A8) are stained. Faint
signal is observed in one cell in the thoracic ganglion
(T2dm), more medial than the Tv1–3 cells (Fig. 1), and
one cell in the subesophageal ganglion (Sv), more lateral
than the SE2 cell (Fig. 2). The same pattern of expres-
sion was observed in tissue dissected from larvae at
48 h.
Immunoreactive fibers project from some cells of
which the most striking are those that project from the
MP1 cells. One immunoreactive fiber extends posterior-
ly to the ventral ganglion, while another extends medial-
ly, crosses over the midline, and continues posteriorly
parallel to the midline to traverse the entire ventral gan-
glion and extend out of the central nervous system. The
MP1 cells also send immunoreactive fibers anteriorly,
passing close to the SP cells, with arborizations in the
superior protocerebrum (Figs. 1 and 2).
The DSK I/II staining pattern in pupal neural tissue is
similar to that observed in larval neural tissue (Figs. 3a,
b). Multiple cells in the superior protocerebrum, two
cells in the medial protocerebrum (MP1), one cell in the
lateral protocerebrum (LP1), one cell in the subesopha-
geal ganglion (SE2), another cell in the subesophageal
ganglion (Sv), more lateral than the SE2 cell, and one
cell in each of the three thoracic ganglia (Tv1–3) are
stained. In addition, two cells in the medial protocere-
brum (MP3), lateral to the MP1 cells, are stained. The
intense signal and close proximity of the cells in the su-
perior protocerebrum make it difficult to assess the num-
ber and identity of SP cells stained. In contrast to the ex-
pression pattern in larval tissue, no staining of the T2dm
cell is observed, and the A8 cells are only weakly
stained in pupae. There is an increase in the intensity of
staining and complexity of the immunoreactive fibers
that project from the SP and MP1 cells (Fig. 3a). Immu-
noreactive fibers that project from the SP cells extend in-
to the medial protocerebrum (Fig. 3a). The same pattern
of expression was observed for tissue dissected from pu-
pae at 24 h and 80 h.
The cellular distribution of DSK I/II antisera staining
in adult neural tissue is similar to that observed in larval
and pupal neural tissue; however, the intensity and com-
plexity of the immunoreactive fibers increases signifi-
cantly (Fig. 4). Multiple cells in the superior protocere-
brum, two cells in the medial protocerebrum (MP1), two
Fig. 3a, b. DSK I/II immunoreactivity in pupal neural tissue. a
Immunoreactive material is expressed in SP3, LP1, MP1, MP3,
Sv, and SE3 cells in pupal tissue at 24 h. An enlargement (inset)
of the superior protocerebrum illustrates the immunoreactive fi-
bers that project from the SP cells. b Immunoreactive material is
expressed in Tv1–3 cells in the pupal ventral ganglion at 80 h.
Bar: 50µm&/fig.c:
Fig. 4. DSK I/II immunoreactivity in adult neural tissue at 7 days.
Immunoreactive material is expressed in SP, LP1, MP1, MP3, Sv,
SE2, Tv1–3, and A8 cells. Immunoreactive fibers that project
from the MP1 cells extend into the optic lobe, superior protocere-
brum, subesophageal ganglion, and ventral ganglion. Immunore-
active fibers that project from the SE2 cell extend into the ventral
ganglion. Bar: 50µm&/fig.c:
Fig. 5. DSK II immunoreactivity in larval neural tissue at 48 h.
Immunoreactive material is expressed in the MP1, SE2, and
Tv1–3 cells. Bar: 50µm&/fig.c:
Fig. 6. DSK II immunoreactivity in pupal neural tissue 48 h. Im-
munoreactive material is expressed in the MP1, SE2, and Tv1–3
cells. Bar: 50µm&/fig.c:
Fig. 7. DSK II immunoreactivity in adult neural tissue 7 days. Im-
munoreactive material is expressed in the LP1, MP1, MP3, SE3,
T2dm, and Tv1–3 cells. Bar: 50µm&/fig.c:
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Fig. 8. DSK 0 immunoreactivity in larval neural tissue 96 h. Im-
munoreactive material is expressed in the brain in SP1, SP2, SP3,
LP1, and MP1 cells, and in the ventral ganglion in SE2, Sv,
T3dm, Tv1–3, VC, and A8 cells. Bar: 50µm&/fig.c:
Fig. 9. DSK 0 immunoreactivity in larval superior protocerebrum
at 96 h. Immunoreactive fibers project from SP2 cells and extend
into the medial protocerebrum&/fig.c:
Fig. 10. DSK 0 immunoreactivity in pupal neural tissue at 48 h.
Immunoreactive material is expressed in SP1, SP2, SP3, LP1,
MP1, MP3, SE2, and Tv1–3 cells. Bar: 50µm&/fig.c:
Fig. 11. DSK 0 immunoreactivity in adult neural tissue at 7 days.
Immunoreactive material is expressed in SP1, SP2, LP1, MP1,
MP3, SE2, and Tv1–3 cells. Bar: 50µm&/fig.c:
cells in the medial protocerebrum (MP3), lateral to the
MP1 cells, one cell in the lateral protocerebrum (LP1),
one cell in the subesophageal ganglion (SE2), one cell in
the subesophageal ganglion (Sv), more lateral than the
SE2 cell, and one cell in each of the three thoracic gan-
glia (Tv1–3) are stained. The intense signal from the im-
munoreactive fibers and numerous varicosities in the su-
perior protocerebrum make it difficult to assess the num-
ber and identity of SP cells stained. In contrast to the ex-
pression pattern in larval neural tissue, only one A8 cell
and no staining of the T2dm cell is observed; however,
the complexity and intensity of the immunoreactive fi-
bers present in the ventral ganglion could easily have ob-
scured the presence of a A8 cell and a T2dm cell.
In the adult, the immunoreactive fibers extending
from the MP1 cells are similar to those observed in both
the larva and pupa; however, the complexity and level of
staining has increased markedly in the medial and supe-
rior protocerebrum and the thoracic ganglion. In addi-
tion, an immunoreactive fiber that extends from the MP1
cells projects to the optic lobe and then branches with
extensive arborization throughout it.
DSK II immunoreactivity
DSK II-immunoreactive material was first detected in
tissue dissected from larvae (Fig. 5). Two medial proto-
cerebrum cells (MP1), one subesophageal ganglion cell
(SE2), and one cell in each of the three thoracic ganglia
(Tv1–3) are stained. Faint signal is observed in fibers
that project from the MP1 cells, extend medially, cross
over the midline, and continue posteriorly extending
along the midline into the ventral ganglion. The MP1
cells also send immunoreactive fibers anteriorly with ar-
borizations in the superior protocerebrum. The pattern of
expression was the same for tissue dissected from larvae
at 24 h and 96 h (data not shown).
The DSK II staining pattern in pupal neural tissue is
similar to that observed in larval neural tissue (Fig. 6).
Two medial protocerebrum cells (MP1), one subesopha-
geal ganglion cell (SE2), and one cell in each of the
three thoracic ganglion (Tv1–3) are stained. The pattern
of expression was the same for tissue dissected from pu-
pae at 24 h and 48 h (data not shown).
The DSK II staining pattern in adult neural tissue is
similar to that observed in larval and pupal neural tissue
(Fig. 7). Two medial protocerebrum cells (MP1), one
subesophageal ganglion cell (SE2), and one cell in each
of the three thoracic ganglia (Tv1–3) are stained. In ad-
dition to those cells that have stained in both larval and
pupal neural tissue, one lateral protocerebrum cell
(LP1), and two cells in the medial protocerebrum (MP3),
lateral to the MP1 cells, are stained.
DSK 0 immunoreactivity
DSK 0 staining is first detected in neural tissue dissect-
ed from embryos at 13–16 h. Faint signal is observed in
a cell in the subesophageal ganglion (SE2) and two
cells in the medial protocerebrum (MP1; data not
shown).
Numerous cells express DSK 0-immunoreactive ma-
t rial in neural tissue dissected from larvae at 96 h
(Fig. 8). The staining pattern was the same for tissue dis-
sected from larvae at 50 h and 96 h. Multiple cells in the
superior protocerebrum (SP1, SP2, and SP3), two cells
in the medial protocerebrum (MP1), one cell in the later-
al protocerebrum (LP1), one cell in the subesophageal
ganglion (SE2), one cell in each of the three thoracic
ganglion (Tv1–3), one cell more medial than the three
thoracic ganglion cells (T3dm), and seven cells posi-
tioned in a line or chain parallel to the midline in the
ventral ganglion (VC) are stained. One cell in the eighth
abdominal ganglion (A8) and one cell in the subesopha-
geal ganglion (Sv), lateral to the SE2 cell, stain less in-
tensely. The staining of SP1, SE2, and Tv1–3 cells was
observed in tissue dissected from larvae at 10 h (data not
shown) and SP2 and VC cells, as well as SP1, SE2, and
Tv1–3 cells, were observed in tissue dissected from lar-
vae at 20 h (data not shown).
Immunoreactive fibers projecting from all three SP2
cells are characteristic of DSK 0 antisera staining
(Fig. 9). These fibers extend medially and posteriorly
parallel to the midline, while other fibers appear to
branch from these SP2 tracts and project posteriorly at a
more lateral point than the first set of tracts.
The DSK 0 staining pattern in pupal tissue is similar
to that observed in larval neural tissue (Fig. 10). Multi-
ple cells in the superior protocerebrum (SP1, SP2, and
SP3), two cells in the medial protocerebrum (MP1), one
cell in the lateral protocerebrum (LP1), one cell in the
subesophageal ganglion (SE2) and another more lateral
cell (Sv), and one cell in each of the three thoracic gan-
glia (Tv1–3) are stained. In contrast to the expression
pattern in larval tissue, no staining of Sv, T3dm, VC, or
A8 cells is observed, while two cells (MP3) in the medi-
al protocerebrum, more lateral than the MP1 cells, are
stained. In addition, there is an increase in signal intensi-
ty and arborization of the immunoreactive fibers in the
thoracic ganglia. The SE2, Tv1–3, MP1, SP2, SP3, and
LP1 cells are stained in tissue dissected from pupae at
48 h and 72 h. However, the staining of the MP3 cell,
observed in tissue dissected from pupae at 48 h and 72 h,
is not present in tissue dissected from pupae at 24 h (da-
ta not shown).
The DSK 0 staining in adult tissue is similar to that
observed in larval and pupal neural tissue (Fig. 11). Mul-
tiple cells in the superior protocerebrum (SP1, SP2, and
SP3), two cells in the medial protocerebrum (MP1), one
cell in the lateral protocerebrum (LP1), two cells (MP3)
in the medial protocerebrum, lateral to the MP1 cells,
one cell in the subesophageal ganglion (SE2), and one
cell in each of the three thoracic ganglia (Tv1–3) are
stained. In contrast to the expression pattern in larval tis-
sue, no staining of Sv, T3dm, VC, or A8 cells is ob-
served.
In this manuscript, cells are identified based on posi-
tion when comparing DSK and FMRFamide staining or
the individual DSK peptide expression patterns; howev-
er, our preliminary double-label immunocytochemical
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studies indicate that these assignments are correct. For
instance, those cells stained by each of the three DSK
antisera are also stained by FMRFamide antisera, and
cells stained by DSK II are stained by DSK I/II antisera.
Discussion
To study the structure and expression of Drosophilaneu-
ropeptides, we have isolated the naturally occurring pep-
tides and raised antisera to the peptides. The generation
f sequence-specific antisera to Drosophila neuropep-
tides provides the opportunity to study the expression of
the individual peptides, as well as to determine whether
structurally related peptides are co-expressed. In addi-
tion, sequence-specific antisera serve as valuable tools
for the analysis of Drosophila mutants in studying the
function and the regulation of expression of neuropep-
tides.
In this manuscript we describe the spatial and tempo-
ral expression of DSK neuropeptides using antisera
raised to three different antigens. It is important to note
Fig. 12.Schematic illustration of
DSK I/II- and DSK II-immunore-
active materials in Drosophila
melanogaster. The cellular distri-
bution of immunoreactive material
is illustrated for all stages of devel-
opment&/fig.c:
Fig. 13.Schematic illustration
of DSK 0-immunoreactive materi-
al in Drosophila melanogaster.
The cellular distribution of immu-
noreactive material is illustrated
for all stages of development
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that there is a limitation in interpreting the immunocyto-
chemical data presented because of the structure similar-
ity between DSK I and DSK II. Since the polyclonal an-
tisera raised to DSK I detect both DSK I and DSK II, a
cell stained by both DSK I/II antisera and DSK II antise-
ra may contain DSK I and DSK II, or DSK II alone. We
cannot resolve this ambiguity; however, the data report-
ed using DSK I antisera and DSK II antisera do contrib-
ute to the current understanding of sulfakinin expression.
Expression of DSK-immunoreactive material begins
in the embryo and continues with an increase in the
number of cells stained and an increase in the intensity
of staining, as well as an increase in arborization of the
immunoreactive fibers. DSK I/II immunoreactivity is ex-
pressed in cell bodies and fibers in the brain lobe, optic
lobe, subesophageal ganglion, thoracic ganglia, and an
abdominal ganglion. In addition, we observed an in-
tensely staining immunoreactive fiber that projects from
an abdominal ganglion in larval tissue to an, as yet, un-
identified target site.
DSK II-immunoreactive material is present in Dro-
sophila melanogasterneural tissue throughout postem-
bryonic development. The cellular distribution of DSK II
immunoreactivity is a subset of those cells stained by
DSK I/II antisera (Fig. 12). These results can be inter-
preted to indicate that those cells stained by DSK I/II an-
tisera, but not stained by DSK II antisera, express DSK I
but not DSK II, suggesting that the drosulfakinin precur-
sor may undergo cell-specific processing. Alternative ex-
planations are that the amount of DSK II expressed in
some cells is lower than our detection level or that DSK
II is released more rapidly than DSK I.
The staining of cells with DSK II antisera suggests
that DSK II is expressed, a finding that is consistent with
our peptide isolation study to identify -RFamide-immu-
noreactive materials in Drosophila melanogasterin
which N-terminal sequence data for DSK II were ob-
tained (Nichols, 1992a, b). The amount of DSK II recov-
ered in the peptide isolation study was substantially low-
er than for DSK I, an observation that is consistent with
the level of staining observed with DSK I/II antisera and
DSK II antisera.
DSK 0-immunoreactive material is expressed in Dro-
sophila melanogasterneural tissue throughout develop-
ment (Fig. 13). The specificity of DSK 0 antisera and the
pattern of DSK 0 immunoreactivity suggests that DSK 0
or a DSK 0-like material is expressed in cells that contain
DSK I and DSK II. Although the cellular distribution of
DSK 0 immunoreactivity is similar to those cells stained
by DSK I/II antisera, one striking difference exists – the
staining of the VC cells by DSK 0 antisera. The VC cells
or ventral chain of seven cells stain intensely and consis-
tently with DSK 0 antisera. DSK 0 antisera preincubated
with FMRFamide or SFamide also stain the VC cells;
however, neither DSK I/II nor DSK II antisera stain the
VC cells. In addition, the VC cells have been reported to
be weakly and inconsistently stained with FMRFamide
antisera (Schneider et al. 1991). Taken together, these re-
sults suggest that the VC cells contain DSK 0 or a pep-
tide that is structurally more similar to DSK 0 than to
FMRFamide, DSK I, or DSK II.
Our immunocytochemical data indicate that DSK I-,
DSK II-, and DSK 0-immunoreactive materials are ex-
pressed in many of the same cells throughout develop-
ment, e.g., the subesophageal ganglion cell (SE2), the
two medial protocerebrum cells (MP2), the three thorac-
ic cells (Tv1–3), the lateral protocerebrum cell (LP1),
and the two lateral medial protocerebrum cells (MP3).
However, some cells, e.g., a subesophageal cell (Sv), the
abdominal ganglion cells (A8), and the ventral chain
cells (VC), do not contain all three DSK peptides. Possi-
ble explanations for these differences in expression in-
clude cell-specific processing of the sulfakinin precur-
sor, a difference in antisera titers, or the presence of
structurally related antigens.
During development some cells no longer stained by
DSK antisera, e.g., the VC cells, are stained only in lar-
val tissue by DSK 0 antisera. Based on our current data,
we do not know if the variation in staining results from
cell death or regulation of expression.
Sulfakinin immunoreactivity in Calliphora vomito-
ria (Duve et al. 1994) is not similar to that observed in
Drosophila melanogaster. While this observation may
be species related, other potential reasons for the dif-
ference may be technical. For example, Duve et al.
1994 raised antisera to AspGlnPheAspAspTyr(SO3H)
GlyHisMetArgPheamide and distinguished immunore-
activity originating from sulfakinin from structurally
related peptides by preincubating the antisera with
FMRFamide prior to use in immunocytochemistry. In
contrast, our DSK I/II antisera, produced to PheAsp-
AspTyrGlyHisMetArgPheamide, were purified on a
FMRFamide peptide affinity column to remove any an-
tisera recognizing MRFamide, a structure shared by
DSK I, DSK II, and FMRFamide-related peptides.
Duve et al. 1994 detected only four pairs of sulfakinin-
immunoreactive cells in the entire Calliphora central
nervous system – much like our initial study, which
used low titer DSK-specific antisera and detected a
limited number of cells in brain tissue (Nichols 1992a).
Their polyclonal antisera, reported to have a high titer
as detected by radioimmunoassay, may have contained
a high percentage of RFamide antisera, or antisera not
specific to sulfakinins, which would have bound FMRF-
amide during preincubation of the antisera prior to im-
munocytochemistry.
In this study we present data to support the conclu-
sion that DSK II- and DSK 0-immunoreactive material,
as well as DSK I, are expressed in Drosophila melano-
gasterneural tissue. The observed cellular expression of
DSK-immunoreactive materials in the protocerebrum,
optic lobe, subesophageal ganglion, thoracic ganglia,
and an abdominal ganglion throughout development sug-
gests that the DSK peptides may act as hormones, modu-
lators, or transmitters in several functions. The extensive
pattern of DSK-immunoreactive fibers connecting the
thoracic and abdominal ganglia with the protocerebrum
and subesophageal ganglion, as well as extensive arbori-
zation of immunoreactive fibers from the medial proto-
cerebrum to the optic lobe, suggests an important role
for DSK peptides in integrating or regulating large por-
tions of the central nervous system.
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